Ligne de temps

Timothée Bruel
Chef(fe) de Groupe
13 déc. 2023
publication

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

Lire plus
14 juin 2023
publication

Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.

Lire plus
01 juin 2023
publication

Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.

Lire plus
14 févr. 2023
publication

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.

Lire plus
24 janv. 2023
team

Activités Antivirales des Anticorps

Lire plus
17 nov. 2022
publication

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.

Lire plus
05 oct. 2022
publication

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.

Lire plus
01 sept. 2022
publication

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.

Lire plus
27 août 2022
publication

IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies.

Lire plus
08 juil. 2022
publication

Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination.

Lire plus
04 juil. 2022
publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Lire plus
17 juin 2022
news

New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

Lire plus
01 juin 2022
publication

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.

Lire plus
04 mai 2022
publication

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.

Lire plus
12 mars 2022
publication

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.

Lire plus
02 févr. 2022
publication

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells.

Lire plus
01 févr. 2022
publication

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Lire plus
01 janv. 2022
publication

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.

Lire plus
01 nov. 2021
publication

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.

Lire plus
17 sept. 2021
publication

Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.

Lire plus
01 sept. 2021
publication

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.

Lire plus
18 août 2021
news

Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2 infection

Lire plus
01 août 2021
publication

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

Lire plus
22 juil. 2021
news

SARS-CoV-2 : induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance

Lire plus
08 juil. 2021
publication

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

Lire plus
08 juin 2021
news

Covid-19, un an après : persistance des anticorps protecteurs et réduction significative du risque de réinfection

Lire plus
18 mai 2021
publication

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.

Lire plus
01 avr. 2021
publication

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020

Lire plus
01 janv. 2021
publication

Characteristics Associated with Olfactory and Taste Disorders in COVID-19.

Lire plus
01 déc. 2020
publication

Syncytia formation by SARS-CoV-2-infected cells.

Lire plus
02 sept. 2020
publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Lire plus
01 sept. 2020
publication

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

Lire plus
05 févr. 2020
publication

Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells.

Lire plus
15 oct. 2019
project

3D Pasteur

Lire plus
01 juin 2019
publication

Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice.

Lire plus
01 août 2018
publication

A human immune system mouse model with robust lymph node development.

Lire plus
23 févr. 2018
publication

Correction: Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection.

Lire plus
13 oct. 2017
publication

HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels

Lire plus
14 juin 2017
publication

Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.

Lire plus
01 mai 2017
publication

Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity

Lire plus
15 mars 2017
publication

Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.

Lire plus
15 mars 2017
publication

CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses

Lire plus
25 janv. 2017
publication

Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies

Lire plus
10 oct. 2016
publication

CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge

Lire plus
12 sept. 2016
publication

[Antibodies that kill HIV-1-infected cells]

Lire plus
03 mars 2016
news

Antibodies capable of eliminating HIV-infected cells

Lire plus
03 mars 2016
publication

Elimination of HIV-1-infected cells by broadly neutralizing antibodies

Lire plus
01 janv. 2016
publication

Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles.

Lire plus
01 juil. 2015
publication

SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells

Lire plus
11 mai 2015
team

Virus and Immunity

Lire plus
14 janv. 2015
publication

Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses

Lire plus
26 nov. 2014
publication

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread

Lire plus
30 janv. 2014
publication

Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques

Lire plus
12 janv. 2012
publication

Porcine colon explants in the study of innate immune response to Entamoeba histolytica

Lire plus
21 déc. 2011
publication

Towards the establishment of a porcine model to study human amebiasis

Lire plus
13 avr. 2010
publication

Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy

Lire plus
06 janv. 2010
publication

Epithelial induction of porcine suppressor of cytokine signaling 2 (SOCS2) gene expression in response to Entamoeba histolytica

Lire plus